First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus

Purpose: To assess the difference of the first-line therapy for Helicobacter pylori in patients with or without type 2 diabetes (DM) and to investigate the clinical factors influencing treatment outcomes. Patients and methods: In total, 719 patients with H. pylori infection were treated with 7-day s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Chih-Chien, Kuo, Chung-Mou, Hsu, Chien-Ning, Yang, Shih-Cheng, Wu, Cheng-Kun, Tai, Wei-Chen, Liang, Chih-Ming, Wu, Keng-Liang, Huang, Chih-Fang, Bi, Kuo-Wei, Lee, Chen-Hsiang, Chuah, Seng-Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554512/
https://www.ncbi.nlm.nih.gov/pubmed/31239721
http://dx.doi.org/10.2147/IDR.S194584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554512/
https://www.ncbi.nlm.nih.gov/pubmed/31239721
http://dx.doi.org/10.2147/IDR.S194584

Ejemplares similares